LONG [eLong,] 6-K: Dan Lynn, who is the Managing Director and

[Dan Lynn, who is the Managing Director and Vice President APAC of Expedia, Mr.Lynn leads Expedias business in theia Pacific,luding current business and expansion into new markets. Prior to his current role, Mr.Lynn held a variety of positions at Expedia,luding Vice Present of Global Paid Search Marketing, Director of Strategy andnsumer Insights, and Business Development]

By | 2016-02-07T01:14:06+00:00 February 22nd, 2011|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments

GIGM [GIGAMEDIA] CORRESP: February 21, 2011 VIA FACSIMILE AND EDGAR Ms.

[February 21, 2011 VIA FACSIMILE AND EDGAR Ms. Kathleen Collins Accounting Branch Chief Division of Corporation Finance One Station Place 100 F Street N.E. Re: GigaMedia Limited Form 20-F for the Fiscal Year Ended December 31, 2009 Filed June 30, 2010 Form 6-K filed January 28, 2011 File No. 000-30540 Dear Ms. Collins: Form 20-F for the Fiscal Year Ended]

SEED [Origin Agritech] 6-K: (Original Filing)

[Origin Agritech Limited Reports Unaudited First Quarter Financial Results for Three Months Ended December 31, 2010 Deferred Revenues and Advances from Customers increases 15.71% from RMB 515.7 million at Q1 2010 to RMB 596.7 million at Q1 2011 Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--February 22, 2011-- FINANCIAL RESULTS OVERVIEW During the first quarter of fiscal]

By | 2016-03-10T20:11:38+00:00 February 22nd, 2011|Categories: Chinese Stocks, SEC Original, SEED|Tags: , , , , , |0 Comments

SEED [Origin Agritech] 6-K: Origin Agritech Limited Reports Unaudited First Quarter Financial

[Origin Agritech Limited Reports Unaudited First Quarter Financial Results for Three Months Ended December 31, 2010 Deferred Revenues and Advances from Customers increases 15.71% from RMB 515.7 million at Q1 2010 to RMB 596.7 million at Q1 2011 Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--February 22, 2011-- FINANCIAL RESULTS OVERVIEW During the first quarter of fiscal]

By | 2016-03-10T20:12:33+00:00 February 22nd, 2011|Categories: Chinese Stocks, SEED, Webplus ver|Tags: , , , , , |0 Comments

GURE [GULF RESOURCES] 8-K/A: (Original Filing)

[ASSET PURCHASE AGREEMENT BETWEEN SHOUGUANG CITY HAOYUAN CHEMICAL COMPANY LIMITED, GULF RESOURCES, INC. AND Jinjin Li and Qiuzhen Wang DATED AS OF June 7, 2010 1 1. Asset Checklist 2 This ASSET PURCHASE AGREEMENT (this "AGREEMENT") is entered into as of June 7, 2010 (the "Effective Date") by and between the following Parties: (1) SHOUGUANG CITY HAOYUAN CHEMICAL COMPANY LIMITED,] []

By | 2016-03-18T08:48:18+00:00 February 22nd, 2011|Categories: Chinese Stocks, GURE, SEC Original|Tags: , , , , , |0 Comments

GURE [GULF RESOURCES] 8-K/A: ASSET PURCHASE AGREEMENT BETWEEN SHOUGUANG CITY HAOYUAN CHEMICAL

[ASSET PURCHASE AGREEMENT BETWEEN SHOUGUANG CITY HAOYUAN CHEMICAL COMPANY LIMITED, GULF RESOURCES, INC. AND Jinjin Li and Qiuzhen Wang DATED AS OF June 7, 2010 1 1. Asset Checklist 2 This ASSET PURCHASE AGREEMENT (this "AGREEMENT") is entered into as of June 7, 2010 (the "Effective Date") by and between the following Parties: (1) SHOUGUANG CITY HAOYUAN CHEMICAL COMPANY LIMITED,] []

By | 2016-03-18T08:49:07+00:00 February 22nd, 2011|Categories: Chinese Stocks, GURE, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports Record Second Quarter Fiscal Year 2011 Financial Results February 14, 2011 CHENGDU, China, Feb. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011. Second quarter fiscal] [Tianyin Pharmaceutical, Inc. Second Quarter Fiscal Year 2011 Earnings Results February 15, 2011 Operator: Good morning, ladies and gentleman, and thank you for standing by. Welcome to the Tianyin Pharmaceutical Inc. Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode, and following the presentation, instructions will be given for the question and answer session. Should] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 15, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 7 –]

By | 2016-03-27T21:22:28+00:00 February 22nd, 2011|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Skip to toolbar